Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials

Fig. 3

Estimates of probability of an unfavourable outcome by treatment arm and by intermediate marker. a Time to culture negative status on LJ. b Time to culture negative status in MGIT. c BA(0–56), daily rate of change in log10(TTP) to day 56. d Time to smear negative. Vertical solid and dashed lines show various centiles of the intermediate markers for patients in the control arm in the REMoxTB trial

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us